These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21210724)

  • 1. Scaling down of a clinical three-dimensional perfusion multicompartment hollow fiber liver bioreactor developed for extracorporeal liver support to an analytical scale device useful for hepatic pharmacological in vitro studies.
    Zeilinger K; Schreiter T; Darnell M; Söderdahl T; Lübberstedt M; Dillner B; Knobeloch D; Nüssler AK; Gerlach JC; Andersson TB
    Tissue Eng Part C Methods; 2011 May; 17(5):549-56. PubMed ID: 21210724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
    Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies.
    Hoffmann SA; Müller-Vieira U; Biemel K; Knobeloch D; Heydel S; Lübberstedt M; Nüssler AK; Andersson TB; Gerlach JC; Zeilinger K
    Biotechnol Bioeng; 2012 Dec; 109(12):3172-81. PubMed ID: 22688505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of primary liver cell reorganization in three-dimensional high-density bioreactors for extracorporeal liver support: an immunohistochemical and ultrastructural study.
    Zeilinger K; Holland G; Sauer IM; Efimova E; Kardassis D; Obermayer N; Liu M; Neuhaus P; Gerlach JC
    Tissue Eng; 2004; 10(7-8):1113-24. PubMed ID: 15363168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-free culture of primary human hepatocytes in a miniaturized hollow-fibre membrane bioreactor for pharmacological in vitro studies.
    Lübberstedt M; Müller-Vieira U; Biemel KM; Darnell M; Hoffmann SA; Knöspel F; Wönne EC; Knobeloch D; Nüssler AK; Gerlach JC; Andersson TB; Zeilinger K
    J Tissue Eng Regen Med; 2015 Sep; 9(9):1017-26. PubMed ID: 23165723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cells.
    Karlsson JE; Heddle C; Rozkov A; Rotticci-Mulder J; Tuvesson O; Hilgendorf C; Andersson TB
    Drug Metab Dispos; 2010 Apr; 38(4):705-14. PubMed ID: 20071452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor.
    Mueller D; Tascher G; Müller-Vieira U; Knobeloch D; Nuessler AK; Zeilinger K; Heinzle E; Noor F
    J Tissue Eng Regen Med; 2011 Aug; 5(8):e207-18. PubMed ID: 21442764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
    Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
    Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicompartmental Hollow-Fiber-Based Bioreactors for Dynamic Three-Dimensional Perfusion Culture.
    Schmelzer E; Gerlach JC
    Methods Mol Biol; 2016; 1502():1-19. PubMed ID: 27075977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
    Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
    Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates.
    Flendrig LM; la Soe JW; Jörning GG; Steenbeek A; Karlsen OT; Bovée WM; Ladiges NC; te Velde AA; Chamuleau RA
    J Hepatol; 1997 Jun; 26(6):1379-92. PubMed ID: 9210627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
    Bucher S; Le Vee M; Jouan E; Fardel O
    J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylated poly(vinylidene difluoride) hollow fiber bioreactor for hepatocyte culture.
    Lu HF; Lim WS; Zhang PC; Chia SM; Yu H; Mao HQ; Leong KW
    Tissue Eng; 2005; 11(11-12):1667-77. PubMed ID: 16411812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor.
    De Bartolo L; Salerno S; Morelli S; Giorno L; Rende M; Memoli B; Procino A; Andreucci VE; Bader A; Drioli E
    Biomaterials; 2006 Sep; 27(27):4794-803. PubMed ID: 16753210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfabricated grooved substrates as platforms for bioartificial liver reactors.
    Park J; Berthiaume F; Toner M; Yarmush ML; Tilles AW
    Biotechnol Bioeng; 2005 Jun; 90(5):632-44. PubMed ID: 15834948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
    Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor.
    Memoli B; De Bartolo L; Favia P; Morelli S; Lopez LC; Procino A; Barbieri G; Curcio E; Giorno L; Esposito P; Cozzolino M; Brancaccio D; Andreucci VE; d'Agostino R; Drioli E
    Biomaterials; 2007 Nov; 28(32):4836-44. PubMed ID: 17706279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial flow bioreactor outperforms hollow-fiber modules as a perfusing culture system for primary porcine hepatocytes.
    Morsiani E; Galavotti D; Puviani AC; Valieri L; Brogli M; Tosatti S; Pazzi P; Azzena G
    Transplant Proc; 2000 Dec; 32(8):2715-8. PubMed ID: 11134773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.